Spero Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Spero Therapeutics (NASDAQ:SPRO) Stock Crosses Below Two Hundred Day Moving Average of $1 50

Spero Therapeutics, Inc. (NASDAQ:SPRO – Get Free Report)’s share price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $1.50 and traded as low as $1.41. Spero Therapeutics shares last traded at $1.45, with a volume of 113,012 shares traded. Analyst Ratings Changes Several equities […]

United statesCantor fitzgeraldSpero therapeutics incMurchinson ltdVirtu financialVanguard group incCapital managementAcadian asset managementSpero therapeuticsGet free reportAsset managementSpero therapeutics daily

Verve Therapeutics Announces Leadership Update

Troy Lister, Ph.D., to be promoted to chief scientific officer Andrew Bellinger, M.D., Ph.D., will depart the Company and serve in an advisory capacity BOSTON, May 31, 2024 Verve.

United statesFlinders universitySouth australiaTroy listerJen robinsonAndrew bellingerSekar kathiresanAshlea kosikowskiExchange commissionScripps research instituteNovartis institutes for biomedical researchVerve therapeutics incChief scientific officerChief medical officerSpero therapeuticsNovartis institutes

Verve Therapeutics Announces Leadership Update - Verve Therapeutics (NASDAQ:VERV)

Verve Therapeutics Announces Leadership Update - Verve Therapeutics (NASDAQ:VERV)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Flinders universitySouth australiaUnited statesSekar kathiresanJen robinsonTroy listerAshlea kosikowskiAndrew bellingerExchange commissionVerve therapeutics incScripps research instituteNovartis institutes for biomedical researchChief scientific officerChief medical officerSpero therapeuticsNovartis institutes

DelveInsight Business Research, LLP: Global Urinary Tract Infection Testing Market to Grow Rapidly at a Growth Rate of ~6% by 2030

The surge in urinary tract infection testing demand is mainly propelled by the increasing worldwide instances of UTIs, the rise in hospital-acquired UTIs, and the preference for home and self-testing

United statesEvofem biosciencesShruti thakurB braun melsungenSumitomo dainippon pharmaDornier medtechWalz elektronik gmbRichard wolf gmbPrnewswire delveinsightCenters for diseaseJm urinary cathetersNational healthcare safety networkTract infection testing market companySinovent pty ltdSysmex corporationBio rad laboratories inc

SPRO Stock Earnings: Spero Therapeutics Misses EPS, Misses Revenue for Q1 2024

SPRO Stock Earnings: Spero Therapeutics Misses EPS, Misses Revenue for Q1 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Market newsStock adviceSpero therapeuticsSpero therapeutics missesMisses revenue